[A case of prostate cancer treated with combined androgen-blockade].
A 62-year-old man was admitted to our hospital because of urinary retention. A digital rectal examination revealed an enlarged, elastic, and hard prostate with an irregular surface. Prostatic biopsy was done and the pathological diagnosis was moderately differentiated adenocarcinoma. He was diagnosed as stage D2 by bone scan and MRI. We gave him 250 mg of fosfestrol intravenously for 13 days. Afterward, he underwent orchiectomy castrate and was given flutamide for two years. His condition has improved and he has experienced no relapse.
Kurita
M
M
Dept. of Urology, Tone Chuo Hospital.
Kato
Y
Y
Tamura
Y
Y
Suzuki
K
K
Yamanaka
H
H
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000726:Androgen Antagonists / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005485:Flutamide / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology
D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D004054:Diethylstilbestrol; D005485:Flutamide; C004955:fosfestrol